Alcohol touches nearly every major neurotransmitter system in the brain, which is why its effects range from relaxation and euphoria to slurred speech, impaired memory, and, with heavy use, seizures during withdrawal. Even a single drink shifts the balance between inhibitory and excitatory signaling, floods reward circuits with dopamine and endorphins, and alters serotonin activity in ways that affect mood and impulse control. The picture gets more complicated the longer and heavier someone drinks, because the brain actively remodels its own chemistry to compensate.
The Inhibition-Excitation Seesaw
The most immediate and pronounced effect of alcohol on the brain is a one-two punch: it dials up inhibitory signaling and simultaneously dials down excitatory signaling. That combination is what makes you feel relaxed, a little slow, and less coordinated after a couple of drinks.
On the inhibitory side, alcohol enhances the activity of GABA, the brain’s primary “calm down” signal. GABA normally decreases neuronal excitability, and when alcohol boosts its effects at GABA-A receptors, the result is sedation, reduced anxiety, and muscle relaxation.1PubMed Central. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system This is the same mechanism that benzodiazepines like Valium exploit, which is one reason mixing alcohol with those drugs is so dangerous.
On the excitatory side, alcohol suppresses glutamate, the brain’s main “go” signal. Specifically, even low doses of alcohol can inhibit the NMDA receptor, a glutamate receptor critical for alertness, learning, and memory formation.2PubMed Central. Alcohol and glutamate So the brain gets a double dose of quieting: more inhibition plus less excitation. That imbalance underlies most of the acute effects people associate with being drunk, from slowed reflexes to difficulty forming new memories.
Dopamine, Opioids, and the Reward Circuit
Alcohol does not just sedate the brain. It also activates reward pathways, which is why drinking feels pleasurable and why the urge to keep drinking can be so strong. This happens through at least two overlapping systems.
First, even low doses of alcohol increase dopamine release in the nucleus accumbens, a brain region central to motivation and reward.3PubMed Central. Alcohol and dopamine That dopamine surge produces a sense of pleasure and reinforces the behavior that caused it, essentially teaching the brain that drinking is worth repeating. Over time, this reinforcement loop contributes to the transition from casual drinking to compulsive use.
Second, alcohol stimulates the release of endogenous opioid peptides, including beta-endorphin, in brain regions tied to reward.4PubMed Central. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism These are the brain’s own morphine-like chemicals. One model suggests that alcohol activates mu-opioid receptors in the ventral tegmental area and delta-opioid receptors in the nucleus accumbens, and that this activation mediates at least part of the rewarding feeling of a drink.5PubMed. Endogenous opioid systems and alcohol addiction The opioid system is also why naltrexone, a medication that blocks opioid receptors, can reduce the pleasure people get from alcohol and help prevent relapse.
Serotonin and Mood
Serotonin’s role in alcohol’s effects is less obvious to the drinker but clinically significant. Both short-term and long-term alcohol exposure alter serotonin receptors, and serotonin appears to contribute to alcohol’s intoxicating and rewarding effects.6PubMed Central. Serotonin’s role in alcohol’s effects on the brain Abnormalities in the serotonin system also appear to play a role in the brain processes underlying alcohol abuse.
This connection helps explain a common clinical observation: many people with alcohol use disorder also struggle with depression or anxiety, conditions tied to serotonin dysfunction. It is not always clear which came first. Some people drink to manage mood symptoms driven by serotonin imbalances; meanwhile, chronic drinking itself disrupts serotonin receptors and can worsen or create mood disorders. Drugs that act on serotonin receptors have been shown to alter alcohol consumption in both humans and animals, which confirms the link runs in both directions.
Other Neurotransmitter Systems Alcohol Touches
GABA, glutamate, dopamine, opioids, and serotonin get the most attention, but alcohol’s reach extends further than that. Several other signaling systems are affected in ways researchers are still mapping out.
The endocannabinoid system, which is the same system that cannabis activates, is involved in alcohol’s effects on both the brain and the liver. Evidence accumulated over the past two decades indicates that both the addictive neural effects of alcohol and its organ-damaging effects are mediated, to a significant extent, by endocannabinoids signaling through CB1 receptors.7PubMed Central. Interactions Between Alcohol and the Endocannabinoid System This overlap may help explain why heavy drinkers and heavy cannabis users sometimes show similar patterns of reward-seeking behavior.
Nicotinic acetylcholine receptors also interact with alcohol, which sheds light on why drinking and smoking so often go together. Alcohol enhances the function of some nicotinic receptor subtypes while inhibiting others.8PubMed Central. Alcohol’s actions on neuronal nicotinic acetylcholine receptors Research suggests that alcohol interacts with these receptors, both directly and indirectly, in the brain’s dopamine-driven reward circuitry, which may give nicotinic receptors an inherent role in alcohol’s addictive properties and in nicotine-alcohol co-dependence.9Frontiers in Psychiatry. Neuronal Nicotinic Acetylcholine Receptors: Common Molecular Substrates of Nicotine and Alcohol Dependence
There is also the adenosine system, which helps regulate sleep and alertness. Alcohol infusion has been shown to increase availability of adenosine A1 receptors by up to about a quarter in several brain regions.10Proceedings of the National Academy of Sciences. Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A1 receptors That finding is interesting because it suggests a molecular overlap between alcohol’s sedative effects and the cognitive impairment people experience when sleep-deprived. Some people are consistently more vulnerable to both alcohol and sleep deprivation, hinting at shared trait-level biology.
Even alcohol’s primary metabolite, acetaldehyde, appears to be biologically active in the brain rather than just a toxic byproduct. When ethanol is broken down by the enzyme catalase inside the brain, the resulting acetaldehyde can itself stimulate locomotor activity. Blocking catalase reduces alcohol’s motor-stimulating effects, which suggests that some of what we attribute to “alcohol” is really the work of acetaldehyde acting on brain circuits.11Neuropsychopharmacology. Motor Stimulant Effects of Ethanol Injected into the Substantia Nigra Pars Reticulata: Importance of Catalase-Mediated Metabolism and the Role of Acetaldehyde
How the Brain Adapts to Chronic Drinking
The neurotransmitter effects described above apply to acute drinking. When someone drinks heavily over weeks, months, or years, the brain does not simply sit passively in that altered state. It pushes back, remodeling its own receptor landscape to counteract alcohol’s effects. This is the basis of tolerance, the phenomenon where the same amount of alcohol produces less of an effect over time.
Chronic alcohol exposure decreases the production of certain GABA-A receptor subunits (alpha1 and alpha2) while increasing others (alpha4), effectively making the brain less responsive to GABA’s calming influence. At the same time, the brain ramps up excitatory signaling by greatly increasing levels of the NR2B subunit of the NMDA glutamate receptor.12PubMed. Comparison of chronic ethanol and chronic intermittent ethanol treatments on the expression of GABA(A) and NMDA receptor subunits In plain terms, the brain is trying to restore the balance that alcohol keeps tipping. It turns down its own brakes and revs up its accelerator.
While alcohol is still present, this compensation is partially masked. The person needs more alcohol to feel the same effects, but their nervous system stays in a precarious equilibrium. The danger becomes apparent the moment alcohol is removed.
What Happens During Withdrawal
When a heavy drinker stops abruptly, all the compensatory changes that built up during chronic use are suddenly unmasked. The brain is now running with weakened inhibition and supercharged excitation, and there is no alcohol left to tip the balance back. The result is a hyperexcitable nervous system that can produce anxiety, tremors, insomnia, and in severe cases, seizures.
Studies of people in early alcohol detoxification show higher levels of glutamate in the brain on the first day compared to healthy controls, consistent with a hyperexcitable state.13PubMed Central. Cortical Glutamate and GABA Changes During Early Abstinence in Alcohol Dependence and Their Associations With Benzodiazepine Medication Lab studies paint a vivid picture of what this looks like at the cellular level: withdrawal from chronic alcohol exposure triggers prolonged seizure-like electrical activity in neurons, and this activity is entirely dependent on NMDA receptor activation.14The Journal of Pharmacology and Experimental Therapeutics. Aberrant Synaptic Activation of N-Methyl-d-aspartate Receptors Underlies Ethanol Withdrawal Hyperexcitability The upregulated NR2B receptors that developed during chronic drinking are now driving runaway excitation with nothing to counterbalance them.
This is why medically supervised detoxification typically involves benzodiazepines. They temporarily substitute for the missing alcohol at GABA-A receptors, buying the brain time to readjust its receptor balance without the dangerous hyperexcitability that could cause seizures or worse.
Alcohol and Memory Formation
Blackouts, where someone cannot recall events that happened while they were drinking, are probably the most familiar alcohol-related memory problem. But the disruption to memory goes deeper than just blacking out at a party.
Memory formation depends on a process called long-term potentiation, where repeated signaling between neurons strengthens their connections. Recent research on brain slices has shown that applying ethanol prevents this strengthening at synapses between the hippocampus, a region essential for memory, and the nucleus accumbens. Chronic intermittent alcohol exposure abolishes long-term potentiation at these synapses even after at least 72 hours of forced abstinence, suggesting persistent synaptic dysfunction that outlasts the period of intoxication.15bioRxiv. Alcohol disrupts long-term potentiation at hippocampus-medium spiny neuron synapses in the medial shell of the nucleus accumbens This finding held for both males and females in the study, with no significant sex difference in the effect.
The practical implication is sobering: the damage to memory circuits from repeated heavy drinking may not fully resolve during short breaks between binges. The synapses stay impaired even when the alcohol has cleared.
Neuroinflammation From Repeated Drinking
Beyond the direct effects on neurotransmitter receptors, chronic alcohol use triggers an immune response inside the brain itself. Alcohol consumption increases levels of innate immune signaling molecules in the brain, and microglia, the brain’s resident immune cells, respond by activating inflammatory pathways involving Toll-like receptors, pro-inflammatory cytokines, and other signaling molecules.16PubMed Central. The role of neuroimmune signaling in alcoholism
This neuroinflammation is not just a side effect. It feeds back into the neurotransmitter disruption and addiction cycle. Inflammatory signals alter how neurons function, can damage brain tissue over time, and appear to contribute to the compulsive drinking patterns seen in alcohol use disorder. Stress amplifies the problem, because it activates many of the same immune pathways in the brain. For people who drink heavily and also experience chronic stress, the neuroinflammatory burden compounds.
Sex Differences in Dopamine Response
Not everyone’s brain responds to alcohol identically, and biological sex is one important variable. Sex steroid hormones modulate dopamine release, receptor levels, and drug-related dopamine activity. In women, dopamine response tends to peak during phases of the menstrual cycle when estradiol is dominant, and estradiol appears to enhance dopamine release while progesterone reduces dopamine activity in the context of substance use.17PubMed Central. Preclinical and clinical sex differences in the effects of alcohol on measures of brain dopamine: a systematic review
What is frustrating is that most of this evidence comes from animal studies or from research on smoking rather than alcohol specifically. A systematic review found that none of the existing studies on alcohol and dopamine had directly examined how sex steroid hormones influence the relationship. This is a significant gap, because it means the dopamine-related reward response to alcohol may look quite different in women depending on hormonal status, and clinicians currently have limited data to guide them.
Epigenetic Changes That Outlast the Drinking
Some of the most unsettling findings in alcohol research involve epigenetics, changes to how genes are read without altering the DNA sequence itself. Chronic alcohol exposure triggers chromatin remodeling, which changes gene expression in specific brain regions and contributes to tolerance and dependence.18PubMed Central. The epigenetic landscape of alcoholism
This is not abstract. In people with alcohol use disorder, researchers have found increased DNA methylation at the promoter region of genes involved in neurosteroid production in the cerebellum, which could reduce the brain’s ability to produce calming neurosteroids on its own.19International Journal of Neuropsychopharmacology. Epigenetic Regulation of GABAergic Neurotransmission and Neurosteroid Biosynthesis in Alcohol Use Disorder Animal studies have also linked chronic ethanol exposure to epigenetic modifications on the promoter of the NR2B gene in the hippocampus, and the expression levels of NR2B were positively correlated with alcohol withdrawal severity.20PubMed. Correlation between the epigenetic modification of histone H3K9 acetylation of NR2B gene promoter in rat hippocampus and ethanol withdrawal syndrome
In other words, heavy drinking does not just temporarily shift neurotransmitter activity. It can physically tag genes in ways that alter the brain’s baseline chemistry, potentially for long periods. These epigenetic marks may help explain why relapse risk persists long after someone stops drinking, and why withdrawal symptoms can worsen with repeated cycles of heavy drinking and abstinence.
How Medications Target These Neurotransmitter Systems
Understanding alcohol’s neurotransmitter effects is not just academic. It has led to medications that specifically target the disrupted systems. Two of the most well-studied are naltrexone and acamprosate, and they work on different pieces of the puzzle.
Naltrexone is a competitive blocker at mu-opioid receptors. Its anti-relapse action likely works because endogenous opioids are involved in alcohol’s rewarding effects and in the conditioned anticipation of those effects.21PubMed. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence By blocking the receptors, naltrexone dulls the “buzz,” making drinking less pleasurable and reducing the craving triggered by environmental cues associated with past drinking.
Acamprosate works on the glutamate side. It modulates NMDA receptor activity, decreases brain glutamate levels, and may also have indirect effects on GABA transmission.22PubMed Central. The clinical pharmacology of acamprosate The best explanation for how it prevents relapse is that it calms the hyperexcitable glutamate system that develops during chronic drinking. That system drives the negative feelings and “pseudo-withdrawal” symptoms that can push someone back toward alcohol even weeks or months into sobriety. Acamprosate essentially helps quiet the neural noise left behind by chronic alcohol exposure, making abstinence more tolerable.
Neither medication is a cure, and both work best alongside behavioral treatment. But their existence illustrates something important: the more precisely researchers map alcohol’s neurotransmitter effects, the more targeted the interventions become. Future treatments may address other parts of the puzzle, perhaps the endocannabinoid system, the neuroinflammatory cycle, or even the epigenetic marks that sustain vulnerability to relapse.